Applied BioMath, the industry-leader in applying mechanistic modeling to drug research and development, today announced that Louis J. Latino, Jr. is joining its team as Senior Vice President of Business Development. In this role, Lou will lead the Applied BioMath business development team and continue to develop the company's growth strategy in the biotechnology and pharmaceutical industry.
Lou has amassed thirty-seven years of direct sales and sales management experience, twenty of which have been focused in the Life Science Industries. Lou's experience and expertise lies in helping to build value in start-up and early-stage companies. He has an extensive history of building sales, exceeding revenue goals and increasing profitability. "We are thrilled to welcome Lou to our company," said Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath. "His experience in the Life Sciences is extremely valuable to us at this high growth stage of our company."
Prior to Applied BioMath, Lou was the Executive Vice President of Selventa, a pioneer in delivering actionable understanding of underlying disease and therapeutic biology to the pharmaceutical and biotechnology industries. Lou also held management positions at Accelrys (now Biovia), Geneformatics and Biosym Technologies. "I look forward to working with the Applied BioMath team and its loyal customer base," said Lou. "This is a pivotal time for the integration of mathematical modeling into drug research and development. It's exciting to have a leadership role in helping companies de-risk their drug programs and accelerate drugs to market." Lou holds a Bachelor of Arts in Chemistry from Boston College.
About Applied BioMath
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, helps biotechnology and pharmaceutical companies answer complex, critical Go/No-go decisions in R&D. Applied BioMath leverages biology, proprietary mathematical modeling and analysis technology, high-performance computing, and decades of industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, and the best path forward. Our involvement shortens project timelines, lowers cost, and increases the likelihood of a best-in-class drug. We provide clarity to complex situations, answer otherwise unanswerable questions, and our approach, when validated in the clinic, is 10x more accurate than traditional methodologies.
Applied BioMath and the Applied BioMath logo are trademarks of Applied BioMath, LLC.
Press contact:
Kristen Zannella
kristen.zannella@appliedbiomath.com